Abstract
This feature article provides an overview of the nascent field of pharmacoproteomics, its definitions and role in personalized medicine, and the specifications of pharmacoproteomics in developing countries. The “ideal world view” is outlined on the opportunities for pharmacoproteomics in the developing countries, for example, research in the fields of neglected tropical diseases and the potential merger of traditional holistic eastern medicine approaches and the practice of personalized medicine. An innovation analysis is performed on the distribution of pharmacoproteomics publications across the countries, and the types of publications (original research versus reviews). Pharmacoproteomics publications in the developing countries are analyzed in further detail, revealing the lower percentage of original research and higher percentage of reviews illustrating both the intention to develop pharmacoproteomics and the limitations in resources and access to the high-end proteomics instrumentation.
Keywords: Developing countries, global personalized medicine, neglected tropical diseases, omics data-intensive science, pharmacoproteomics.
Current Pharmacogenomics and Personalized Medicine
Title:Proteins Do Matter: Pharmacoproteomics Low Hanging Fruits for Global Health and Applications in Developing Countries
Volume: 10 Issue: 4
Author(s): Victor P. Andreev
Affiliation:
Keywords: Developing countries, global personalized medicine, neglected tropical diseases, omics data-intensive science, pharmacoproteomics.
Abstract: This feature article provides an overview of the nascent field of pharmacoproteomics, its definitions and role in personalized medicine, and the specifications of pharmacoproteomics in developing countries. The “ideal world view” is outlined on the opportunities for pharmacoproteomics in the developing countries, for example, research in the fields of neglected tropical diseases and the potential merger of traditional holistic eastern medicine approaches and the practice of personalized medicine. An innovation analysis is performed on the distribution of pharmacoproteomics publications across the countries, and the types of publications (original research versus reviews). Pharmacoproteomics publications in the developing countries are analyzed in further detail, revealing the lower percentage of original research and higher percentage of reviews illustrating both the intention to develop pharmacoproteomics and the limitations in resources and access to the high-end proteomics instrumentation.
Export Options
About this article
Cite this article as:
Andreev P. Victor, Proteins Do Matter: Pharmacoproteomics Low Hanging Fruits for Global Health and Applications in Developing Countries, Current Pharmacogenomics and Personalized Medicine 2012; 10 (4) . https://dx.doi.org/10.2174/187569212803901747
DOI https://dx.doi.org/10.2174/187569212803901747 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Identification of Functional Peptides from Natural and Synthetic Products on Their Anticancer Activities by Tumor Targeting
Current Medicinal Chemistry Qigefang Inhibits Migration, Invasion, and Metastasis of ESCC by Inhibiting Gas6/Axl Signaling Pathway
Recent Patents on Anti-Cancer Drug Discovery Paclitaxel Formulations: Challenges and Novel Delivery Options
Current Drug Delivery COVID-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice
Infectious Disorders - Drug Targets Organoids as <i>Ex Vivo</i> Culture System to Investigate Infection-host Interaction in Gastric Pre-carcinogenesis
Recent Advances in Inflammation & Allergy Drug Discovery Natural Sesquiterpenoids as Cytotoxic Anticancer Agents
Mini-Reviews in Medicinal Chemistry The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target
Current Cancer Drug Targets E-Cadherin Upregulation as a Therapeutic Goal in Cancer Treatment
Mini-Reviews in Medicinal Chemistry Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream
Anti-Cancer Agents in Medicinal Chemistry Novel Anticancer Strategy Aimed at Targeting Shelterin Complexes by the Induction of Structural Changes in Telomeric DNA: Hitting two Birds with one Stone
Current Cancer Drug Targets Is There a Role for Antioxidants in the Prevention of Infection-Associated Carcinogenesis and in the Treatment of Infection-Driven Tumors?
Current Topics in Medicinal Chemistry CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment
Current Pharmaceutical Design Is there any Role for Splenectomy in Adulthood Onset Chronic Immun e Thrombocytopenia in the Era of TPO Receptors Agonists? A Critic al Overview
Cardiovascular & Hematological Disorders-Drug Targets Conjugates of Curcumin with Graphene and Carbon Nanotubes: A Review on Biomedical Applications
Current Medicinal Chemistry Arsenic trioxide Alters the MicroRNA Expression Profile of U87 glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Oxidative Stress and Antioxidants in Carcinogenesis and Integrative Therapy of Cancer
Current Pharmaceutical Design Intravoxel Incoherent Motion Diffusion-weighted MRI Assessing the Effect of the Vascular Disrupting Agent CA4P on VX2 Liver Tumors in Rabbits
Current Medical Imaging The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
Current Pharmaceutical Design MDM2 Increases Drug Resistance in Cancer Cells by Inducing EMT Independent of p53
Current Medicinal Chemistry The Balancing Act between Colonisers and Inflammation: T regulatory and TH17 Cells in Mucosal Immunity during Otitis Media
Current Immunology Reviews (Discontinued)